scholarly article | Q13442814 |
P50 | author | Mira Edgerton | Q88247586 |
P2093 | author name string | Slavena Vylkova | |
Xuewei S Li | |||
Jennifer C Berner | |||
P2860 | cites work | Candidacidal activities of human lactoferrin peptides derived from the N terminus | Q24290527 |
Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans | Q24537545 | ||
Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5 | Q28205819 | ||
A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway | Q28273563 | ||
Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance | Q31136813 | ||
Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization | Q33977671 | ||
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. | Q33980976 | ||
Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation | Q34130303 | ||
Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins | Q35107874 | ||
Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans | Q37085706 | ||
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes | Q37662088 | ||
The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, Histatin 5. | Q38335411 | ||
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans | Q40433088 | ||
Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms | Q40638341 | ||
Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides | Q41307316 | ||
Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization | Q42013682 | ||
beta-defensin expression in immunocompetent and immunodeficient germ-free and Candida albicans-monoassociated mice | Q42467013 | ||
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans | Q42540712 | ||
Defensins from insects and plants interact with fungal glucosylceramides | Q47398270 | ||
Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5. | Q52519123 | ||
Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. | Q52522425 | ||
A helical region on human lactoferrin. Its role in antibacterial pathogenesis. | Q52532252 | ||
Characterization of Histatin 5 with Respect to Amphipathicity, Hydrophobicity, and Effects on Cell and Mitochondrial Membrane Integrity Excludes a Candidacidal Mechanism of Pore Formation | Q60314973 | ||
The Cellular Target of Histatin 5 onCandida albicansIs the Energized Mitochondrion | Q60314983 | ||
Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity | Q68929515 | ||
HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae | Q73545330 | ||
Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death | Q77926810 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Candida albicans | Q310443 |
P304 | page(s) | 324-331 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides | |
P478 | volume | 50 |
Q90600094 | Adaptation of Candida albicans during gastrointestinal tract colonization |
Q36023412 | Antifungal effects of synthetic human β-defensin 3-C15 peptide. |
Q38089201 | Antimicrobial peptides: to membranes and beyond |
Q36776474 | Bcr1 functions downstream of Ssd1 to mediate antimicrobial peptide resistance in Candida albicans. |
Q36023274 | Biology of the heat shock response and protein chaperones: budding yeast (Saccharomyces cerevisiae) as a model system. |
Q47220163 | Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets |
Q90237600 | Candida albicans Interactions with Mucosal Surfaces during Health and Disease |
Q36898587 | Candida albicans cell wall proteins |
Q33927464 | Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37 |
Q36558457 | Chemical genomic screening of a Saccharomyces cerevisiae genomewide mutant collection reveals genes required for defense against four antimicrobial peptides derived from proteins found in human saliva |
Q35866679 | Epithelial cells and innate antifungal defense. |
Q37159784 | Expression of mouse beta defensin 2 in escherichia coli and its broad-spectrum antimicrobial activity |
Q48163110 | Fungal Strategies to Evade the Host Immune Recognition. |
Q42817490 | Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region |
Q36095359 | Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway |
Q33749981 | Host cell invasion and virulence mediated by Candida albicans Ssa1. |
Q37131510 | Host defense peptides in the oral cavity |
Q26771113 | How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions |
Q28484819 | Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions |
Q35635804 | Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption |
Q57244550 | IL-1β and ADAM17 are central regulators of β-defensin expression in Candida esophagitis |
Q48163141 | Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds. |
Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
Q34454950 | Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum |
Q38079168 | Properties and mechanisms of action of naturally occurring antifungal peptides |
Q33422347 | Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans |
Q45800178 | Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens |
Q33339288 | SSD1 is integral to host defense peptide resistance in Candida albicans |
Q30467494 | Salivary defense proteins: their network and role in innate and acquired oral immunity |
Q37219481 | Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine |
Q37106755 | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis |
Q37576442 | Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm |
Q37215786 | The antifungal plant defensin AtPDF2.3 from Arabidopsis thaliana blocks potassium channels. |
Q33467053 | The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis |
Q46702870 | The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae |
Q40730220 | The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides |
Q37308535 | Trifluoromethanesulfonic acid-based proteomic analysis of cell wall and secreted proteins of the ascomycetous fungi Neurospora crassa and Candida albicans |
Q37098208 | Uptake of the antifungal cationic peptide Histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain |
Q41539981 | β-Defensin 1 plays a role in acute mucosal defense against Candida albicans |
Q61809070 | β-Defensins: Farming the Microbiome for Homeostasis and Health |
Search more.